Edwards Lifesciences EW EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Edwards Lifesciences’s reported figures.
Based on trailing twelve months.
The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edwards Lifesciences's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edwards Lifesciences's EBITDA margin?
- Edwards Lifesciences (EW) reported EBITDA margin of 23.9% in Q1 2026.
- How has Edwards Lifesciences's EBITDA margin changed year-over-year?
- Edwards Lifesciences's EBITDA margin decreased by 16.3% year-over-year, from 28.6% to 23.9%.
- What is the long-term trend for Edwards Lifesciences's EBITDA margin?
- Over 4 years (2021 to 2025), Edwards Lifesciences's EBITDA margin has grown at a -4.5% compound annual growth rate (CAGR), from 129.2% to 107.4%.
- What does EBITDA margin mean?
- Operating cash profitability per sales dollar, before interest, taxes, and non-cash charges.
- How do you interpret EBITDA margin?
- Useful for comparing operating profitability across firms with different depreciation policies and leverage. High EBITDA margin alongside heavy capex can still mean weak free cash flow — pair it with FCF margin.
- How does EBITDA margin compare across companies?
- Widely used to compare capital-intensive businesses on a like-for-like basis. Less meaningful for banks and insurers.